COMPASS Pathways Management
Management criteria checks 3/4
COMPASS Pathways' CEO is Kabir Nath, appointed in Aug 2022, has a tenure of 3.42 years. total yearly compensation is $4.34M, comprised of 14.5% salary and 85.5% bonuses, including company stock and options. directly owns 0.037% of the company’s shares, worth $242.88K. The average tenure of the management team and the board of directors is 3.4 years and 5.1 years respectively.
Key information
Kabir Nath
Chief executive officer
US$4.3m
Total compensation
| CEO salary percentage | 14.48% |
| CEO tenure | 3.4yrs |
| CEO ownership | 0.04% |
| Management average tenure | 3.4yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
Is COMPASS Pathways (NASDAQ:CMPS) Weighed On By Its Debt Load?
Dec 08
Compass Pathways: Maintain Hold Rating With COMP360 Going Beyond TRD Development
Oct 15Is COMPASS Pathways (NASDAQ:CMPS) Using Debt Sensibly?
Aug 07Compass Pathways: Betting On The Future Of Psilocybin Therapy
Feb 28Does COMPASS Pathways (NASDAQ:CMPS) Have A Healthy Balance Sheet?
Jan 04Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity
Nov 01Compass Pathways: Sector-Wide Reality Check Needed Post FDA Lykos MDMA Decision
Aug 19Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies
Jul 08Psychedelics Closer To Commercialization; Compass Far And Away The Leader
May 23COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut?
Apr 25Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play
Feb 08Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth
Dec 06Booker again pushes for easier access to psychedelics for terminally ill patients
Oct 19Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation
Aug 13COMPASS Pathways And The Trillion Dollar Opportunity
Aug 11COMPASS Pathways ADS Q2 2022 Earnings Preview
Aug 03COMPASS Pathways names new CEO
Jul 19Compass Pathways: Shares Look Cheap But Proving Psilocybin Case Won't Be Easy
Jun 30We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely
Apr 28Checking In On Compass Pathways
Mar 02We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth
Dec 29Compass Pathways: Psychedelics For Mental Health
Nov 23Compass Faces Tricky Road To Approval For Its Psychedelic Depressive Therapy
Sep 17CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | -US$237m |
| Jun 30 2025 | n/a | n/a | -US$138m |
| Mar 31 2025 | n/a | n/a | -US$138m |
| Dec 31 2024 | US$4m | US$628k | -US$155m |
| Sep 30 2024 | n/a | n/a | -US$144m |
| Jun 30 2024 | n/a | n/a | -US$139m |
| Mar 31 2024 | n/a | n/a | -US$129m |
| Dec 31 2023 | US$3m | US$595k | -US$118m |
| Sep 30 2023 | n/a | n/a | -US$117m |
| Jun 30 2023 | n/a | n/a | -US$102m |
| Mar 31 2023 | n/a | n/a | -US$95m |
| Dec 31 2022 | US$8m | US$243k | -US$92m |
Compensation vs Market: Kabir's total compensation ($USD4.34M) is about average for companies of similar size in the US market ($USD3.48M).
Compensation vs Earnings: Kabir's compensation has increased whilst the company is unprofitable.
CEO
Kabir Nath (61 yo)
Mr. Kabir Kumar Nath M. A., M. B.A., is Chief Executive Officer and Director of COMPASS Pathways plc from August 1, 2022. He serves as President & CEO at Otsuka America Pharmaceutical, Inc. He served as Pr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.4yrs | US$4.34m | 0.037% $ 242.9k | |
| CFO, Principal Financial Officer & Principal Accounting Officer | 1.8yrs | US$2.43m | 0.012% $ 77.4k | |
| Chief Medical Officer | 4.5yrs | US$1.48m | 0.0021% $ 13.8k | |
| Chief Technology Officer | 4yrs | no data | no data | |
| Senior Vice President of Investor Relations | no data | no data | no data | |
| Chief People Officer | no data | no data | no data | |
| Senior Advisor | 4yrs | no data | no data | |
| Advisor | no data | no data | no data | |
| Chief Research & Development Officer | 1.7yrs | no data | no data | |
| Chief Commercial Officer | 1.5yrs | no data | no data | |
| Chief Patient Officer | 1yr | no data | no data | |
| Company Secretary | 4.8yrs | no data | no data |
Experienced Management: CMPS's management team is considered experienced (3.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.4yrs | US$4.34m | 0.037% $ 242.9k | |
| Member of Scientific Advisory Network | no data | no data | no data | |
| Independent Chairman | 1.3yrs | US$410.44k | 0% $ 0 | |
| Independent Director | 7.7yrs | US$411.56k | 0.021% $ 140.5k | |
| Independent Director | 2.3yrs | US$277.54k | 0% $ 0 | |
| Independent Non Executive Director | 5.4yrs | US$282.79k | 0% $ 0 | |
| Independent Non-Executive Director | 4.8yrs | US$276.79k | 0% $ 0 | |
| Independent Non-Executive Director | 7.7yrs | US$271.79k | 0.093% $ 614.4k | |
| Independent Non-Executive Director | 7.7yrs | US$290.28k | 0.020% $ 134.4k | |
| Member of Scientific Advisory Network | no data | no data | no data | |
| Member of Scientific Advisory Network | no data | no data | no data | |
| Special Advisor of Patient Experience | no data | no data | no data |
Experienced Board: CMPS's board of directors are considered experienced (5.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/02 06:09 |
| End of Day Share Price | 2025/12/31 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
COMPASS Pathways plc is covered by 18 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Thomas Shrader | BTIG |
| Sumant Satchidanand Kulkarni | Canaccord Genuity |
| Charles Duncan | Cantor Fitzgerald & Co. |